Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Diagnostic News

12/6/2024
BreakingDiagnosticGlaucomaPerimetry
Konan Medical Launches ObjectiveField Perimeter in US
Konan Medical Launches ObjectiveField Perimeter in US

Konan Medical has launched its ObjectiveField visual field analyzer in the US. The ObjectiveField is an objective perimeter designed to detect visual field abnormalities using pupillary responses. ...

12/6/2024
AIBreakingDealsDiagnosticFundusGlaucomaRetina
Avant, Ainnova Advancing Low-Cost Retinal Camera with AI Screening Software
Avant, Ainnova Advancing Low-Cost Retinal Camera with AI Screening Software

Nevada-based Avant Technologies and Ainnova Tech, of Houston, Texas, announced Nov. 20 that the two companies would advance Ainnova’s proprietary low-cost retinal camera packaged with the Vision AI...

11/14/2024
DiagnosticDry EyeNewsletter
ARPA-H Seeks Proposals for Tear Duct-Based Diagnostic System, Plus Custom Dosing Platform
ARPA-H Seeks Proposals for Tear Duct-Based Diagnostic System, Plus Custom Dosing Platform

ARPA-H announced Oct. 18 that it had launched a new program to develop a tear-based biomarker measurement system that can be inserted into the tear duct to provide continuous health monitoring, pai...

11/14/2024
DiagnosticIOLNewsletterOCTRegulation
Select US FDA Approvals and Clearances in October 2024
Select US FDA Approvals and Clearances in October 2024

The US FDA granted four clearances through the ophthalmic device division using the 510(k) pathway in October 2024, according to the agency’s database. Apple gained clearance for its Digital Prism ...

11/14/2024
AIDealsDiagnosticFundingGene TherapyGlaucomaNewsletterRetinaSurgical
EyePoint Leads Latest Ophthalmic Fundraising with $161 Million Public Offering
EyePoint Leads Latest Ophthalmic Fundraising with $161 Million Public Offering

EyePoint Pharmaceuticals led recent ophthalmic fundraising efforts with a $161 million upsized underwritten public offering. Proceeds in part will fund clinical development of Duravyu. Financing an...

11/14/2024
AAODiagnosticNewsletterSurgical
AAO and Eyenuk Collaborate on AI-Driven DR Screening for Underserved Patients
AAO and Eyenuk  Collaborate on AI-Driven  DR Screening for  Underserved Patients

Eyenuk and the American Academy of Ophthalmology (AAO) reported Oct. 16 that they had teamed up under the AAO’s EyeCare America program to provide eye disease screening for underserved communities ...

11/14/2024
DiagnosticMicroscopesNewsletterSurgical
Haag-Streit’s Metis Poised to Join Innovation-Rich and Growing Advanced Microscopes Segment
Haag-Streit’s Metis Poised to Join Innovation-Rich and Growing Advanced Microscopes Segment

Haag-Streit revealed its new Metis microscope at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting and showcased it again at the 2024 AAO meeting. The Metis is specifica...

11/14/2024
AIDiagnosticEmergingGlaucomaNewsletterOcular CancerRegulationRetinaTelehealth
Emerging Companies Pursuing Ophthalmic Indications, November 2024
Emerging Companies Pursuing Ophthalmic Indications, November 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

11/14/2024
CataractClinical TrialDealsDiagnosticDry EyeFundingGene TherapyGlaucomaIndustryInstrumentsMicroscopesNewsletterOCTPresbyopiaRegulationRetinaStudySurgical
November 2024 Ophthalmic News Briefs
November 2024 Ophthalmic News Briefs

Heidelberg Engineering announced Oct. 14 that the US FDA had granted 510(k) clearance to its Flex Module for the Spectralis diagnostic imaging platform. The Flex Module mounts the Spectralis to a m...

10/25/2024
BreakingDiagnosticDry EyeFundingStudy
ARPA-H Seeks Proposals for Tear Duct-Based Diagnostic System, Plus Custom Dosing Platform
ARPA-H Seeks Proposals for Tear Duct-Based Diagnostic System, Plus Custom Dosing Platform

ARPA-H announced Oct. 18 that it had launched a new program to develop a tear-based biomarker measurement system that can be inserted into the tear duct to provide continuous health monitoring, pai...

10/18/2024
AAOAIBreakingDiagnosticRetinaSurgical
Eyenuk, AAO Collaborate to Offer AI-Driven DR Screening for Underserved Patients in Delaware
Eyenuk, AAO Collaborate to Offer AI-Driven DR Screening for Underserved Patients in Delaware

Eyenuk and the American Academy of Ophthalmology (AAO) reported Oct. 16 that they had teamed up under the AAO’s EyeCare America program to provide eye disease screening for underserved communities ...

10/18/2024
BreakingDiagnosticOCTRegulation
US FDA Grants 510(k) Clearance to Flex Module for Heidelberg Spectralis OCT
US FDA Grants 510(k) Clearance to Flex Module for Heidelberg Spectralis OCT

Heidelberg Engineering announced Oct. 14 that the US FDA had granted 510(k) clearance to its Flex Module for the Spectralis diagnostic imaging platform. The Flex Module mounts the Spectralis to a m...

10/15/2024
AIDealsDiagnosticDigitalFundingMyopiaNewsletterPharmaPresbyopiaRetina
Orasis Leads Latest Ophthalmic Deals with $78 Million Financing
Orasis Leads Latest Ophthalmic Deals with $78 Million Financing

Orasis Pharmaceuticals led recent ophthalmic fundraising efforts with $78 million in Series D and structured capital to support the launch of Qlosi drops for presbyopia. Financing announced in the ...

10/15/2024
CornealDiagnosticGlaucomaLaserNewsletterRegulation
Select US FDA Approvals and Clearances in September 2024
Select US FDA Approvals and Clearances in September 2024

The US FDA granted two clearances through the ophthalmic device division using the 510(k) pathway in September 2024, according to the agency’s database. Zeiss gained clearance for its combination Y...

10/15/2024
DiagnosticDry EyeEmergingLow VisionNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, October 2024
Emerging Companies Pursuing Ophthalmic Indications, October 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

10/15/2024
ChinaClinical TrialDealsDiagnosticDry EyeEuropeGene TherapyGlaucomaIndiaIndustryLaserNewsletterPerimetryRegulationRetinaSurgical
October 2024 Ophthalmic News Briefs
October 2024 Ophthalmic News Briefs

Oculus has announced the addition of frequency doubling perimetry (FDP) to its Easyfield VR visual field diagnostic headset. The German ophthalmic diagnostic company, with US headquarters in Arling...

10/11/2024
BreakingDiagnosticMicroscopes
Beyeonics One Introduces ‘Invisible Light’ Infrared Illumination
Beyeonics One Introduces ‘Invisible Light’ Infrared Illumination

Israel’s Beyeonics Vision announced Oct. 8 that it had incorporated “invisible light” technology, based on infrared night vision, into the Beyeonics One surgical visualization system. Beyeonics sai...

10/11/2024
BreakingDiagnosticGlaucoma
iCare Launches ST500 Slit Lamp Mounted Rebound Tonometer
iCare Launches ST500 Slit Lamp Mounted Rebound Tonometer

Finland’s iCare, a subsidiary of Revenio Group, has launched its iCare ST500 rebound tonometer that can be attached to a slit lamp. The device gained US FDA 510(k) clearance on Sept. 27. The compan...

9/20/2024
AIBreakingDiagnosticIndiaRegulationRetina
Indian Regulators Approve First Ophthalmic AI Software—Medios DR from Remidio
Indian Regulators Approve First Ophthalmic AI Software—Medios DR from Remidio

India’s Remidio announced Sept. 13 that regulators there had approved its Medios DR software for autonomous detection of diabetic retinopathy (DR). Medios DR becomes the first ophthalmic artificial...

9/19/2024
DiagnosticNewsletterRefractive
Zeiss Plans to Use Creal's Technology to Reimagine Refractive Exams
Zeiss Plans to Use Creal's Technology to Reimagine Refractive Exams

Zeiss will integrate Swiss company Creal’s light field display technology into its refractive diagnostic equipment under a collaboration agreement, the two companies reported Sept. 10. Creal descri...

9/19/2024
DeviceDiagnosticGlaucomaNewsletter
Injectsense Reports First Human Implantation of Ultraminiature IOP Sensor
Injectsense Reports First Human Implantation of Ultraminiature IOP Sensor

Injectsense, of Emeryville, California, announced Aug. 27 that it had implanted its first ultraminiature wireless sensor for measuring intraocular pressure (IOP). Glaucoma specialist Juan Mura, MD,...

9/19/2024
DiagnosticNewsletterRegulation
Select US FDA Approvals and Clearances in August 2024
Select US FDA Approvals and Clearances in August 2024

The US FDA granted four clearances through the ophthalmic device division using the 510(k) pathway in August 2024, according to the agency’s database. Notably, newcomer Intelon Optics received clea...

9/19/2024
AIDealsDiagnosticNewsletterRetina
Revenio’s iCare Subsidiary Acquires AI Screening Company Thirona Retina
Revenio’s iCare Subsidiary Acquires AI Screening Company Thirona Retina

Finland’s Revenio Group announced Aug. 20 that its iCare subsidiary had assumed ownership of the Dutch artificial intelligence (AI) software company Thirona Retina. iCare had made a minority invest...

9/19/2024
AmblyopiaClinical TrialDiagnosticFundusGene TherapyGlaucomaIndustryNewsletterRegulationRetinaSurgical
September 2024 Ophthalmic News Briefs
September 2024 Ophthalmic News Briefs

Bausch + Lomb is working with Goldman Sachs to explore a sale of the company, the Financial Times reported Sept. 14, with private equity the most likely buyer. The move is being evaluated as a way ...

9/13/2024
BreakingDiagnosticNewsletterRefractive
Zeiss Plans to Use Creal's Technology to Reimagine Refractive Exams
Zeiss Plans to Use Creal's Technology to Reimagine Refractive Exams

Zeiss will integrate Swiss company Creal’s light field display technology into its refractive diagnostic equipment under a collaboration agreement, the two companies reported Sept. 10. Creal descri...

9/13/2024
BreakingDiagnosticGlaucomaPerimetry
Oculus Debuts Frequency Doubling Perimetry with Easyfield VR
Oculus Debuts Frequency Doubling Perimetry with Easyfield VR

Oculus has announced the addition of frequency doubling perimetry (FDP) to its Easyfield VR visual field diagnostic headset, along with standard automated perimetry. The German ophthalmic diagnosti...

9/6/2024
BreakingClinical TrialDiagnosticGlaucoma
Injectsense Completes First Human Implantation of its Ultraminiaturized IOP Sensor
Injectsense Completes First Human Implantation of its Ultraminiaturized IOP Sensor

Injectsense, of Emeryville, California, announced Aug. 27 that it had implanted its first ultraminiature wireless sensor for measuring intraocular pressure (IOP). Glaucoma specialist Juan Mura, MD,...

9/6/2024
BreakingDiagnosticFundusRetina
Visionix Unveils its VX 610 Automated Fundus Camera
Visionix Unveils its VX 610 Automated Fundus Camera

Visionix USA has announced the launch of its VX 610 non-mydriatic automated fundus camera. The VX 610 boasts a range of automated features, including auto alignment, auto focus, and auto capture, w...

8/30/2024
AIBreakingDealsDiagnosticEuropeGlaucomaRetina
Revenio’s iCare Subsidiary Acquires AI Screening Company Thirona Retina
Revenio’s iCare Subsidiary Acquires AI Screening Company Thirona Retina

Finland’s Revenio Group announced Aug. 20 that its iCare subsidiary had assumed ownership of the Dutch artificial intelligence (AI) software company Thirona Retina. iCare had made a minority invest...

8/21/2024
DiagnosticDry EyeFundingGene TherapyLaserNewsletterRetina
MeiraGTx Leads Latest Ophthalmic Fundraising with $50 Million Offering
MeiraGTx Leads Latest Ophthalmic Fundraising with $50 Million Offering

MeiraGTx led recent ophthalmic fundraising efforts with a $50 million offering of ordinary shares as it moves forward with its extensive pipeline of gene therapy candidates. Financing announced in ...

8/16/2024
BiosimilarsBreakingCataractDiagnosticDry EyeGlaucomaLaserOcular CancerRefractiveRetinaRevenueSurgical
Q2-2024 Ophthalmic Revenue Roundup for AbbVie, Carl Zeiss Meditec, Amgen, STAAR, Astellas, Immunocore, Tarsus, Biogen, Lensar, and Iridex
Q2-2024 Ophthalmic Revenue Roundup for AbbVie, Carl Zeiss Meditec,  Amgen, STAAR, Astellas, Immunocore, Tarsus, Biogen, Lensar, and Iridex

AbbVie, of North Chicago, Illinois, reported July 25 that Q2-2024 net revenue for its eye care products totaled $533 million, a 13.3 percent decline (-10.9 percent cc) from $617 million in Q2-2023....

8/2/2024
BreakingCornealDiagnosticDry EyeGlaucomaIOLLaserRetinaRevenueSurgical
Q2-2024 Ophthalmic Revenue Roundup for Regeneron, Roche, Bausch + Lomb, Novartis, and Four Others
Q2-2024 Ophthalmic Revenue Roundup for Regeneron, Roche, Bausch + Lomb, Novartis, and Four Others

Regeneron, of Tarrytown, New York, reported Aug. 1 that its Q2-2024 US revenue for Eylea was $1.53 billion, a 2 percent increase from $1.5 billion in Q2-2023. Eylea HD accounted for $304 million of...

7/26/2024
BreakingCornealDealsDiagnosticDry EyeSurgical
Bausch + Lomb Acquires Dry Eye Diagnostic Company Trukera Medical
Bausch + Lomb Acquires Dry Eye Diagnostic Company Trukera Medical

Bausch + Lomb announced July 23 that it had acquired dry eye diagnostic company Trukera Medical from its private equity owner, AccelMed Partners, and other shareholders. No financial details were d...

7/23/2024
DiagnosticDigitalFundusNewsletterOCTTelehealth
Digital Enhancements Reshape $3.7 Billion Ophthalmic Diagnostic Equipment Market
Digital Enhancements Reshape $3.7 Billion Ophthalmic Diagnostic Equipment Market

Ongoing investments in digital products designed to enhance ophthalmic diagnostic equipment and associated outputs are signaling a shift away from the fast-paced equipment releases of the early 200...

7/23/2024
DiagnosticNewsletterOCT
EssilorLuxottica Acquires Majority Stake in Diagnostics Maker Heidelberg 
EssilorLuxottica Acquires Majority Stake in Diagnostics Maker Heidelberg

Eyewear conglomerate EssilorLuxottica announced July 17 that it had agreed to acquire an 80 percent stake in Heidelberg Engineering, a leader in ophthalmic diagnostic imaging. Financial details wer...

7/19/2024
BreakingDealsDiagnosticOCT
EssilorLuxottica Acquires Majority Stake in Diagnostics Maker Heidelberg 
EssilorLuxottica Acquires Majority Stake in Diagnostics Maker Heidelberg

Eyewear conglomerate EssilorLuxottica announced July 17 that it had agreed to acquire an 80 percent stake in Heidelberg Engineering, a leader in ophthalmic diagnostic imaging. Financial details wer...

7/19/2024
AIBreakingDiagnosticDigitalIndustry
Eyenuk Appoints Bryan Haardt as Chief Executive Officer
Eyenuk Appoints Bryan Haardt as Chief Executive Officer

Digital health care company Eyenuk, of Los Angeles, California, announced July 18 that it had appointed Bryan Haardt as chief executive officer. Paul Praino, who had been serving as Eyenuk’s interi...

6/28/2024
BreakingDiagnosticRefractiveRegulationTelehealth
Evolution Optiks Receives US FDA 510(k) Clearance for Tele-refactor
Evolution Optiks Receives US FDA 510(k) Clearance for Tele-refactor

Barbados-based Evolution Optiks announced June 4 that it had received 510(k) clearance from the US FDA for the LFR-260, its light field powered subjective tele-refractor. The device gained CE marki...

6/24/2024
DiagnosticFundusGlaucomaIOLNewsletterOCTRegulationSurgical
Select US FDA Approvals and Clearances in May 2024
Select US FDA Approvals and Clearances in May 2024

The US FDA granted six clearances through the ophthalmic device division using the 510(k) pathway in May 2024, according to the agency’s database. Reichert gained market clearance for its new hand-...

6/24/2024
CornealDealsDiagnosticNewsletter
Eversight Partners with LighTopTech to Improve Imaging of Eye Tissues
Eversight Partners with LighTopTech  to Improve Imaging of Eye Tissues

Global nonprofit eye bank Eversight announced June 5 a four-year partnership with LighTopTech to improve imaging for eye tissues in clinical and research settings. Eversight will integrate LighTopT...

6/24/2024
DealsDiagnosticFundingGene TherapyGlaucomaNewsletterPharmaRetinaTelehealth
Opthea Leads Latest Fundraising with $113.2M Placement, Entitlement Offer
Opthea Leads Latest Fundraising with $113.2M Placement, Entitlement Offer

Opthea led recent ophthalmic fundraising efforts with a $113.2 million placement and entitlement offer, as it continues to advance its wet AMD candidate. Financing announced in the past four weeks ...

6/24/2024
DiagnosticEmergingMicroscopesNewsletterPharmaSurgicalTelehealth
Emerging Companies Pursuing Ophthalmic Indications, June 2024
Emerging Companies Pursuing Ophthalmic Indications, June 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

6/24/2024
DiagnosticIOLNewsletterPremium
Weekly Surgeon Poll, June 2024
Weekly Surgeon Poll, June 2024

6/24/2024
CataractClinical TrialData SecurityDealsDiagnosticDry EyeGene TherapyGlaucomaIOLIndustryMyopiaNewsletterRefractiveRegulationRetinaSurgical
June 2024 Ophthalmic News Briefs
June 2024 Ophthalmic News Briefs

Japan’s Nidek announced June 3 that it had launched the RS-1 Glauvas OCT system. The device is CE marked as a Class IIa device. Nidek said the RS-1 Glauvas’ streamlined workflow and advanced analyt...

6/21/2024
BreakingCornealDealsDiagnostic
Eversight Partners with LighTopTech to Improve Imaging of Eye Tissues
Eversight Partners with LighTopTech to Improve Imaging of Eye Tissues

Global nonprofit eye bank Eversight announced June 5 a four-year partnership with LighTopTech to improve imaging for eye tissues in clinical and research settings. Eversight will integrate LighTopT...

6/14/2024
BreakingDiagnosticGlaucomaOCTRetina
Nidek Launches RS-1 Glauvas OCT System
Nidek Launches RS-1 Glauvas OCT System

Japan’s Nidek announced June 3 that it had launched the RS-1 Glauvas optical coherence tomography (OCT) system. The device is CE marked as a Class IIa device. Nidek said the RS-1 Glauvas’ streamlin...

6/7/2024
BreakingDiagnostic
Quantel Medical Launches Pocket III Hand-held Pachymeter
Quantel Medical Launches Pocket III Hand-held Pachymeter

Quantel Medical, a division of France's Lumibird Medical, announced May 30 the launch of the Pocket III hand-held pachymeter to measure the thickness of the cornea. Quantel says the Pocket III ...

5/24/2024
BreakingDiagnosticGlaucoma
Reichert Launches Tono-Vera Hand-held Tonometer in US
Reichert Launches Tono-Vera Hand-held Tonometer in US

Reichert announced May 6 that its Tono-Vera hand-held tonometer is now available in the US. Tono-Vera provides quick, automated, and reliable intraocular pressure measurements with rebound tonomete...

5/22/2024
DiagnosticNewsletterRegulationRetina
US FDA Grants De Novo Authorization to Notal Vision’s Scanly AI-Powered Home OCT
US FDA Grants De Novo Authorization to Notal Vision’s Scanly AI-Powered Home OCT

Notal Vision announced May 16 that the US FDA had granted de novo marketing authorization for its patient-operated Scanly home optical coherence tomography (OCT) device. The Scanly uses artificial ...

5/22/2024
AICataractDiagnosticFundingGene TherapyGlaucomaIOLNewsletterRetina
RxSight Leads Latest Ophthalmic Fundraising with $115 Million Public Offering
RxSight Leads Latest Ophthalmic Fundraising with $115 Million Public Offering

RxSight led recent ophthalmic fundraising efforts with a $115 million public offering to continue commercialization of its Light Adjustable Lens portfolio. Financing announced in the past four week...

5/22/2024
DiagnosticNewsletterRegulation
Select US FDA Approvals and Clearances in April 2023
Select US FDA Approvals and Clearances in April 2023

The US FDA granted two clearances through the ophthalmic device division using the 510(k) pathway in April 2024, according to the agency’s database. Topcon received 510(k) clearance for its Maestro...

5/22/2024
CornealDiagnosticDry EyeEmergingGene TherapyGlaucomaNewsletterOcular CancerRetinaSurgical
Emerging Companies Pursuing Ophthalmic Indications, May 2024
Emerging Companies Pursuing Ophthalmic Indications, May 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

5/22/2024
AIDealsDiagnosticGlaucomaMeetingNewsletterRetinaStudy
Artificial Intelligence Takes Leading Role at 2024 ARVO Meeting
Artificial Intelligence Takes Leading Role at 2024 ARVO Meeting

Artificial intelligence was a prominent topic at the 2024 ARVO meeting. Discussions ranged from using AI in published ophthalmic research to employing it in early detection and monitoring of eye di...

5/22/2024
AIDealsDiagnosticNewsletter
New Topcon Healthcare CEO, Latest Partnerships Stress Focus on ‘Oculomics’
New Topcon Healthcare CEO, Latest Partnerships Stress Focus on ‘Oculomics’

Topcon Healthcare announced April 26 that it had appointed Ali Tafreshi as CEO and president. The company said Tafreshi will lead the company’s focus on “oculomics”—diagnosing not just eye disease ...

5/22/2024
AIDiagnosticNewsletter
Weekly Surgeon and Industry Poll, May 2024
Weekly Surgeon and Industry Poll, May 2024

5/22/2024
CataractChinaCornealDiagnosticDry EyeGlaucomaIndiaMicroscopesNewsletterPharmaRegulationRetina
May 2024 Ophthalmic News Briefs
May 2024 Ophthalmic News Briefs

Taiwan-based Formosa Pharmaceuticals announced May 9 that it had entered into an exclusive licensing agreement with Tabuk Pharmaceuticals to market clobetasol propionate 0.05% eye drops for post-su...

5/17/2024
BreakingDiagnosticOCTRegulation
US FDA Grants De Novo Marketing Authorization to Notal Vision’s Scanly AI-Powered Home OCT
US FDA Grants De Novo Marketing Authorization to Notal Vision’s Scanly AI-Powered Home OCT

Notal Vision announced May 16 that the US FDA had granted de novo marketing authorization for its patient-operated Scanly home optical coherence tomography (OCT) device. The Scanly uses artificial ...

5/17/2024
BreakingDiagnosticDry EyePharmaRetinaRevenueSurgical
Q1-2024 Ophthalmic Revenue Roundup for Alcon, Carl Zeiss Meditec, and Harrow
Q1-2024 Ophthalmic Revenue Roundup for Alcon, Carl Zeiss Meditec, and Harrow

Alcon reported May 13 that its Q1-2024 net sales were $2.4 billion, a 5 percent increase (+7 percent cc) over $2.3 billion in Q1-2023. Surgical net sales totaled $1.34 billion, consisting of $433 m...

5/10/2024
BreakingDiagnosticGlaucoma
First-in-Human Study for Injectsense Implantable IOP Monitor Approved by Chilean Clinic
First-in-Human Study for Injectsense Implantable IOP Monitor Approved by Chilean Clinic

Injectsense announced May 6 that the ethics committee at the Centro de la Vision Clinic in Santiago, Chile, has approved a 20-patient study of the company’s ultra-miniature wireless sensor, designe...

5/10/2024
BreakingChinaDiagnosticRefractive
ArcScan Computer-Controlled Ophthalmic Ultrasound Gains Approval in China
ArcScan Computer-Controlled Ophthalmic Ultrasound Gains Approval in China

ArcScan announced May 1 that its Insight 100 computer-controlled ophthalmic ultrasound imaging device received National Medical Products Administration (NMPA) approval in China. ArcScan, of Denver,...

5/10/2024
BreakingDiagnosticDry EyeEurope
Lumibird Launches C.Diag Diagnostic Platform for Dry Eye
Lumibird Launches C.Diag Diagnostic Platform for Dry Eye

France’s Lumibird Medical announced May 3 that it had launched C.Diag, a dry eye diagnostic imaging platform incorporating artificial intelligence, after gaining the European Union’s CE marking for...

5/10/2024
BreakingDiagnosticFundusRetina
Remidio Places its Thousandth Smartphone-Based Fundus Camera in US
Remidio Places its Thousandth Smartphone-Based Fundus Camera in US

Remidio Inc., the US arm of India-based Remidio, announced May 7 that it had placed its thousandth FOP-NM hand-held fundus camera in the US. Remidio’s FOP-NM is the world’s first smartphone-based n...

5/3/2024
AIBreakingDiagnosticFundusRegulationRetina
US FDA Approves Aeye’s Autonomous AI DR Screening with Hand-held Fundus Camera
US FDA Approves Aeye’s Autonomous AI DR Screening with Hand-held Fundus Camera

Aeye Health announced April 30 that the US FDA had approved the company’s autonomous artificial intelligence-aided screening technology for diabetic retinopathy (DR) using a hand-held retinal camer...

5/3/2024
AIBreakingDiagnosticFundusIndustryRetina
Topcon Healthcare Appoints Ali Tafreshi as President, CEO to Lead Focus on Oculomics
Topcon Healthcare Appoints Ali Tafreshi as President, CEO to Lead Focus on Oculomics

Topcon Healthcare announced April 26 that it had appointed Ali Tafreshi as CEO and president. The company said Tafreshi will lead the company’s focus on “oculomics”—diagnosing not just eye health b...

4/24/2024
AICataractCornealDiagnosticFundingGlaucomaIndiaLaserNewsletterPharmaRetina
Outlook Leads Latest Ophthalmic Fundraising with $164M in Private Placements
Outlook Leads Latest Ophthalmic Fundraising with $164M in Private Placements

Retinal drug developer Outlook Therapeutics led recent ophthalmic fundraising efforts with two private placements, for proceeds totaling $164 million. Financing announced in the past four weeks tot...

4/24/2024
ASCRSDiagnosticDigitalMicroscopesNewsletter
Digital Solutions are Underlying Theme at 2024 ASCRS Meeting
Digital Solutions are Underlying Theme at 2024 ASCRS Meeting

The ASCRS conference was a hub of diagnostic innovation and collaboration, despite the absence of a designated “Digital Day,” as provided at the 2023 meeting. Discussions on the integration of digi...

4/24/2024
Clinical TrialCornealData SecurityDealsDiagnosticDry EyeEnvironmentFundingGlaucomaIOLIndustryMicroscopesNewsletterRegulationRetina
April 2024 Ophthalmic News Briefs
April 2024 Ophthalmic News Briefs

Alexion, the rare disease unit of AstraZeneca, announced March 25 that the US FDA had approved its long-acting C5 complement inhibitor Ultomiris (ravulizumab-cwvz) for adults with neuromyelitis opt...

3/22/2024
BreakingDiagnosticRetinaStudy
AI Has Perfect Detection Rate for Severe Cases of ROP in Study
AI Has Perfect Detection Rate for Severe Cases of ROP in Study

Artificial intelligence can accurately and independently detect 100 percent of severe cases of retinopathy of prematurity (ROP), according to a study published March 7 in the journal JAMA Ophthalmo...

3/21/2024
DiagnosticFundingNewsletterOCT
Washington U. Gets up to $20M ARPA-H Grant to Create Portable OCT
Washington U. Gets up to $20M ARPA-H Grant to Create Portable OCT

Washington University in St. Louis, Missouri, announced Feb. 13 that one of its professors had been awarded a grant of up to $20 million from the Advanced Research Projects Agency for Health (ARPA-...

3/21/2024
CataractDiagnosticGlaucomaNewsletterRefractiveRegulationRetinaSurgical
Select US FDA Approvals and Clearances in February 2024
Select US FDA Approvals and Clearances in February 2024

The US FDA granted two clearances through the ophthalmic device division using the 510(k) pathway in February 2024, according to the agency’s database. CATS Tonometer received clearance for its ton...

3/21/2024
DiagnosticDry EyeFundingNewsletterRetina
Ocular Tx Leads Latest Ophthalmic Fundraising with $325 Million Private Placement
Ocular Tx Leads Latest Ophthalmic Fundraising with $325 Million Private Placement

Ocular Therapeutix led recent ophthalmic fundraising efforts with a $325 million private placement to advance its candidate for wet age-related macular degeneration. Financing announced in the past...

3/21/2024
AllergyDiagnosticDry EyeEmergingGene TherapyGlaucomaNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, March 2024
Emerging Companies Pursuing Ophthalmic Indications, March 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

2/23/2024
BreakingDiagnosticFundingOCT
Washington U. Awarded up to $20 Million Federal Grant to Create Portable OCT
Washington U. Awarded up to $20 Million Federal Grant to Create Portable OCT

Washington University in St. Louis, Missouri, announced Feb. 13 that one of its professors had been awarded a grant of up to $20 million from the Advanced Research Projects Agency for Health (ARPA-...

2/22/2024
CataractClinical TrialCornealDealsDiagnosticDry EyeGene TherapyGlaucomaIOLIndustryNewsletterPresbyopiaRegulationRetinaSurgical
February 2024 Ophthalmic News Briefs
February 2024 Ophthalmic News Briefs

Amneal Pharmaceuticals announced Jan. 10 that it had received US FDA approval for and launched generic fluorometholone eye drops. The product is indicated for the treatment of corticosteroid-respon...

2/9/2024
BreakingDiagnosticEuropeRegulation
Toku Gains EU, UK Approval for AI Cardiovascular Risk Assessments Through the Eye
Toku Gains EU, UK Approval for AI Cardiovascular Risk Assessments Through the Eye

Toku, of San Diego, California, announced Feb. 5 that it had obtained CE and UK Conformity Assessment (UKCA) marking for its patented CLAiR technology—AI-powered software that identifies elevated c...

2/2/2024
BreakingDiagnosticIndustry
Carl Zeiss Meditec Announces Settlement to Topcon Lawsuit Over Trade Secrets
Carl Zeiss Meditec Announces Settlement to Topcon Lawsuit Over Trade Secrets

German company Carl Zeiss Meditec, part of the Zeiss Group, reported Feb. 1 that it had settled a lawsuit it brought against Topcon Medical Systems and Topcon Healthcare Solutions, US subsidiaries ...

1/19/2024
BreakingDiagnosticOCTRetina
Nidek Commercially Launches Mirante Scanning Laser Ophthalmoscope in US
Nidek Commercially Launches Mirante Scanning Laser Ophthalmoscope in US

Nidek announced Jan. 11 that its Mirante scanning laser ophthalmoscope had been launched in the US market. The device was commercialized outside the US in August 2019. The Mirante is a multimodal f...

12/29/2023
BreakingDiagnosticRetinaStudy
AI Model Using Retinal Images Accurately Diagnoses Autism in Korean Study
AI Model Using Retinal Images Accurately Diagnoses Autism in Korean Study

Korean researchers were able to identify all children with autism, with no false positives, using an AI model based on 2D retinal images of the optic disc area. Their findings were published in the...

12/29/2023
BreakingDiagnosticGlaucomaRegulationRetina
iHealthScreen Gains UK Approval for iPredict AI Screener for DR, AMD, and Glaucoma
iHealthScreen Gains UK Approval for iPredict AI Screener for DR, AMD, and Glaucoma

New York-based iHealthScreen announced Dec. 5 that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) had approved its iPredict automated AI screening system for early diagnosis of d...

12/20/2023
BreakingDealsDiagnosticRetina
RetinAI to Provide Connectivity for RIMR Consortium Targeting AMD Biomarkers
RetinAI to Provide Connectivity for RIMR Consortium Targeting AMD Biomarkers

RetinAI reported Nov. 29 that it had joined a global nonprofit consortium of physicians, researchers, and industry partners working to define optimal biomarkers and endpoints in age-related macular...

12/15/2023
BreakingDiagnosticIOLRevenueSurgical
Carl Zeiss Meditec Reports Annual Ophthalmic Revenue of $1.67 Billion
Carl Zeiss Meditec Reports Annual Ophthalmic Revenue of $1.67 Billion

Carl Zeiss Meditec reported Dec. 12 that ophthalmology revenue for is full fiscal year 2022/2023, which ended Sept. 30, was €1.58 billion ($1.67 billion, converted Sept. 30), a 7.3 percent increase...

12/15/2023
BreakingDealsDiagnosticIndiaOCT
Aurolab to Develop Kubota’s At-home OCT Device for South Asia Markets
Aurolab to Develop Kubota’s At-home OCT Device for South Asia Markets

Seattle-based Kubota Vision reported Dec. 6 that it agreed to provide Aurolab, of India, with an exclusive license to develop, manufacture, and distribute eyeMo, Kubota’s low-cost, home-based, self...

12/14/2023
DeviceDiagnosticNewsletterRefractiveRegulation
Select US FDA Approvals and Clearances in November 2023
Select US FDA Approvals and Clearances in November 2023

The US FDA granted three clearances through the ophthalmic device division using the 510(k) pathway in November 2023, according to the agency’s database. Medimaging Integrated Solution (MiiS) recei...

12/14/2023
DiagnosticNewsletterOCT
OCT Inventors Receive 2023 Lasker Award, Most Prestigious US Medical Prize
OCT Inventors Receive 2023 Lasker Award, Most Prestigious US Medical Prize

Three inventors of optical coherence tomography (OCT) have received the 2023 Lasker-DeBakey Clinical Medical Research Award, one of three Lasker Awards given annually. OCT uses light to probe tissu...

12/14/2023
DiagnosticFundingNewsletterRetina
EyePoint Leads Latest Ophthalmic Fundraising with $200 Million Public Offering
EyePoint Leads Latest Ophthalmic Fundraising with $200 Million Public Offering

EyePoint Pharmaceuticals led recent ophthalmic fundraising efforts with a $200 million upsized public offering, as it continues to advance its anti-VEGF implant for retinal disease. Financing annou...

12/14/2023
CataractClinical TrialDealsDiagnosticGene TherapyGlaucomaIndustryNewsletterRegulationRetinaTelehealth
December 2023 Ophthalmic News Briefs
December 2023 Ophthalmic News Briefs

Enzene Biosciences, based in Pune, India, announced in November that it had launched a ranibizumab biosimilar for the treatment of wet age-related macular degeneration (AMD). The product references...

12/1/2023
BreakingDiagnosticRegulationRetina
Zilia Receives US FDA 510(k) Clearance for its Zilia Ocular FC Retinal Camera
Zilia Receives US FDA 510(k) Clearance for its Zilia Ocular FC Retinal Camera

Canadian company Zilia announced Nov. 29 that the US FDA had granted 510(k) clearance to its retinal camera, the Zilia Ocular FC. The company said it would now focus on obtaining de novo classifica...

11/22/2023
BreakingDealsDiagnostic
Keeler and Long Grove Pharmaceuticals Enter Agreement for Distribution of Ak-fluor 
Keeler and Long Grove Pharmaceuticals Enter Agreement for Distribution of Ak-fluor

Ophthalmic company Keeler announced Nov. 15 that it had formed a partnership with Long Grove Pharmaceuticals to distribute Ak-fluor (fluorescein injection) for diagnostic fluorescein angiography. L...

11/21/2023
CornealDiagnosticDry EyeFundingGlaucomaNewsletterRetina
EyeBio Leads Latest Ophthalmic Fundraising with $65 Million in Series A
EyeBio Leads Latest Ophthalmic Fundraising with $65 Million in Series A

EyeBio led recent ophthalmic fundraising efforts with $65 million in Series A funding to continue development of its candidate for retinal disease. Financing announced in the past four weeks totale...

11/21/2023
DiagnosticGlaucomaLaserNewsletterRegulationRetina
Select US FDA Approvals and Clearances in October 2023
Select US FDA Approvals and Clearances in October 2023

The US FDA granted five clearances through the ophthalmic device division using the 510(k) pathway in October 2023, according to the agency’s database. Heidelberg gained market clearance for its An...

11/21/2023
AAODiagnosticDigitalDry EyeGlaucomaMeetingNewsletterRefractiveRegulationRetinaSurgical
Buzzworthy Topics at the 2023 AAO Meeting
Buzzworthy Topics at the 2023 AAO Meeting

Dry Eye: New products kept generating buzz around dry eye. Bausch + Lomb leaned into the promotion of Miebo, the new, first-in-class drug therapy that directly targets tear evaporation. Diagnostic ...

11/21/2023
AAOCataractDiagnosticDigitalGlaucomaMeetingNewsletterSurgical
Diagnostic Leaders Showcase Devices, Collaborations at AAO Meeting
Diagnostic Leaders Showcase Devices, Collaborations at AAO Meeting

Notable diagnostic innovations showcased at the 2023 meeting of the American Academy of Ophthalmology were Topcon’s Tempo perimeter and Heidelberg Engineering’s Anterion anterior OCT platform. Also...

11/21/2023
CornealDiagnosticEmergingGene TherapyGlaucomaNewsletterRetinaSurgical
Emerging Companies Pursuing Ophthalmic Indications, November 2023
Emerging Companies Pursuing Ophthalmic Indications, November 2023

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

11/21/2023
ChinaDealsDiagnosticDry EyeGene TherapyGenericsGlaucomaIndustryNewsletterPresbyopiaRegulationRetinaSurgical
November 2023 Ophthalmic News Briefs
November 2023 Ophthalmic News Briefs

Specialty pharma company Padagis announced Oct. 13 the launch of its brinzolamide ophthalmic suspension, a generic version of Novartis’ Azopt for glaucoma. Padagis, with offices in the US and Israe...

11/17/2023
BreakingDealsDiagnosticOptometryTelehealth
Visionix Forms Strategic Alliance with 20/20Now to Expand Tele-optometry
Visionix Forms Strategic Alliance with 20/20Now to Expand Tele-optometry

Visionix’ US division announced Nov. 10 that it had entered into a strategic alliance with 20/20Now to bring tele-optometry to more optical retailers. 20/20Now, of Holbrook, New York, offers a soft...

11/10/2023
BreakingDiagnosticIndustry
Eye Exam Kiosk Developer EyeCheq Names Ruwan Silva, MD, as Chief Medical Officer
Eye Exam Kiosk Developer EyeCheq Names Ruwan Silva, MD, as Chief Medical Officer

EyeCheq announced Nov. 2 that it had appointed Ruwan Silva, MD, as chief medical officer. Silva completed his residency in ophthalmology at Bascom Palmer Eye Institute in Miami, Florida, and his vi...

11/3/2023
BreakingCataractDiagnosticSurgical
Bausch + Lomb Launches SeeNa Optical Biometry and Topography System in the US
Bausch + Lomb Launches SeeNa Optical Biometry and Topography System in the US

Bausch + Lomb announced on Oct. 30 the US launch of its SeeNa ophthalmic diagnostic system for refractive cataract patients, designed for integration with the company’s Eyetelligence surgical plann...

11/3/2023
BreakingDealsDiagnosticRetina
Aeye Health, Topcon Partner to Deliver AI-Aided Point-of-Care Screening for DR
Aeye Health, Topcon Partner to Deliver AI-Aided Point-of-Care Screening for DR

Aeye Health and Topcon’s diabetic point-of-care eye exam arm, Topcon Screen, announced Oct. 27 that they would partner to deliver artificial intelligence-aided screening for diabetic retinopathy (D...

10/24/2023
DiagnosticNewsletterRegulation
US FDA Approves Ryzumvi from Viatris and Ocuphire for Reversal of Mydriasis
US FDA Approves Ryzumvi from Viatris and Ocuphire for Reversal of Mydriasis

Viatris and Ocuphire Pharma announced Sept. 27 that the US FDA had approved Ryzumvi (phentolamine ophthalmic solution) 0.75% for the reversal of pharmacologically induced mydriasis. Ryzumvi is expe...

10/24/2023
DiagnosticDry EyeFundingNewsletter
Tilak Leads Latest Ophthalmic Fundraising with $10.6 Million Round
Tilak Leads Latest Ophthalmic Fundraising with $10.6 Million Round

France’s Tilak Healthcare led recent ophthalmic fundraising efforts with a $10.6 million funding round for its medical video games for chronic vision disorders. Financing announced in the past four...

10/24/2023
DiagnosticMicroscopesNewsletter
Scope Showdown: Three Strategics Compete for Technical Supremacy
Scope Showdown: Three Strategics Compete for Technical Supremacy

Three of the biggest names in ophthalmic equipment—Alcon, Carl Zeiss Meditec, and Bausch + Lomb—are funneling resources into digital technology, with a focus on streamlining the operating room and ...

10/24/2023
CataractClinical TrialDealsDiagnosticDry EyeGene TherapyGenericsIOLIndustryMicroscopesNewsletterOcular CancerRegulationRetina
October 2023 Ophthalmic News Briefs
October 2023 Ophthalmic News Briefs

Théa Pharma, the US subsidiary of France’s Laboratoires Théa, announced the launch Sept. 26 of once-daily Iyuzeh (latanoprost ophthalmic solution) 0.005% in the US market. Iyuzeh is the first prese...

10/24/2023
ChinaDiagnosticDry EyeEmergingGene TherapyGlaucomaNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, October 2023
Emerging Companies Pursuing Ophthalmic Indications, October 2023

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

10/24/2023
CataractDiagnosticNewsletterSurgical
Weekly Surgeon Poll, October 2023
Weekly Surgeon Poll, October 2023

10/20/2023
BreakingCataractDiagnosticSurgical
US FDA Clears Anterion Anterior Segment Diagnostic Platform from Heidelberg
US FDA Clears Anterion Anterior Segment Diagnostic Platform from Heidelberg

Heidelberg Engineering announced Oct. 13 that the US FDA had cleared its Anterion diagnostic platform for the anterior segment. The system gained CE marking in 2018. The Anterion combines biometry,...

10/20/2023
BreakingDiagnosticDigital
Baxter Launches Digital Image Capture Capability for PanOptic Plus Ophthalmoscope
Baxter Launches Digital Image Capture Capability for PanOptic Plus Ophthalmoscope

Health care company Baxter International announced Oct. 16 the launch of digital image capture capability for eye exams using its Welch Allyn PanOptic Plus ophthalmoscope. The iExaminer Pro System ...

10/13/2023
BreakingDiagnosticIndustryMicroscopes
Olaf Felske is Appointed CEO of Haag-Streit USA
Olaf Felske is Appointed CEO of Haag-Streit USA

Switzerland’s Haag-Streit Group announced Oct. 3 that it had appointed Olaf Felske as the new chief executive officer of Haag-Streit USA, its division based in Mason, Ohio. Haag-Streit USA distribu...

10/6/2023
BreakingDealsDiagnosticRetina
Zeiss Partners With Boehringer Ingelheim to Improve Diagnosis and Treatment of Eye Disease
Zeiss Partners With Boehringer Ingelheim to Improve Diagnosis and Treatment of Eye Disease

German companies Zeiss and Boehringer Ingelheim reported Oct. 2 that they would collaborate long-termon developing predictive analytics to foster earlier detection of eye disease and more personali...

10/6/2023
BreakingDiagnosticOCTRetina
OCT Inventors Receive 2023 Lasker Award, Most Prestigious US Medical Prize
OCT Inventors Receive 2023 Lasker Award, Most Prestigious US Medical Prize

Three inventors of optical coherence tomography (OCT) have received the 2023 Lasker-DeBakey Clinical Medical Research Award, one of three Lasker Awards given annually. OCT uses light to probe tissu...

10/6/2023
BreakingDiagnosticDigitalIndustryMicroscopesSurgical
Joseph C. Papa Joins Beyeonics Surgical as Chairman of the Board
Joseph C. Papa Joins Beyeonics Surgical as Chairman of the Board

Israel’s Beyeonics announced Oct. 4 that ophthalmic industry veteran Joseph C. Papa had joined the company as chairman of the board of Beyeonics Surgical and board member of Beyeonics Vision. Papa ...

9/29/2023
BreakingDiagnosticRegulationRetina
Nexus Pharmaceuticals Gains US FDA Approval for Fluorescein Injection Amid Shortage
Nexus Pharmaceuticals Gains US FDA Approval for Fluorescein Injection Amid Shortage

Nexus Pharmaceuticals, of Lincolnshire, Illinois, announced Sept. 26 that it had gained US FDA approval for its fluorescein injection. Nexus’ fluorescein USP 10% is now available in 5 ml single-dos...

9/22/2023
BreakingDiagnosticRetina
US FDA Clears Expanded FA Capabilities of NeoLight’s Portable Retinal Camera Icon Go
US FDA Clears Expanded FA Capabilities of NeoLight’s Portable Retinal Camera Icon Go

NeoLight announced Sept. 12 that the US FDA had cleared the expanded fluorescein angiography (FA) capabilities of the company’s portable retinal camera Icon Go. The Scottsdale, Arizona, company sai...

9/21/2023
DiagnosticNewsletterStudy
EarliTec’s Eye Tracking System for Autism Gains Attention in Two JAMA Journals
EarliTec’s Eye Tracking System for Autism  Gains Attention in Two JAMA Journals

EarliTec Diagnostics reported Sept. 5 that The Journal of the American Medical Association (JAMA) had released study results for its eye tracking system for autism in two of its publications. The s...

9/21/2023
DiagnosticGlaucomaNewsletterRefractiveRetinaSurgical
Ophthalmic Diagnostic Equipment Market To Grow 3.8 Percent Through 2028, Driven by OCT Systems
Ophthalmic Diagnostic Equipment Market  To Grow 3.8 Percent Through 2028, Driven  by OCT Systems

Market Scope estimates that the ophthalmic diagnostic equipment market will generate $3.7 billion in total revenue in 2023, and the market will grow to $4.4 billion by 2028, for a compound annual g...

9/21/2023
ChinaClinical TrialCornealDealsDiagnosticDry EyeEuropeGene TherapyIndustryNewsletterRefractiveRegulationRetinaSurgical
September 2023 Ophthalmic News Briefs
September 2023 Ophthalmic News Briefs

Carl Zeiss Meditec announced Aug. 23 that more than 8 million eyes had been treated with the company’s SMILE procedure through the first half of 2023. SMILE, short for small-incision lenticule extr...

9/8/2023
BreakingDiagnosticStudy
EarliTec’s Eye Tracking System for Autism Gains Attention in Two JAMA Journals
EarliTec’s Eye Tracking System for Autism Gains Attention in Two JAMA Journals

EarliTec Diagnostics reported Sept. 5 that The Journal of the American Medical Association (JAMA) had released study results for its eye tracking system for autism in two of its publications. The s...

8/25/2023
BreakingDiagnosticDry EyePresbyopiaRetinaRevenueSurgical
Q2-2023 Ophthalmic Revenue Roundup for AbbVie, Carl Zeiss Meditec, Alimera
Q2-2023 Ophthalmic Revenue Roundup for AbbVie, Carl Zeiss Meditec, Alimera

AbbVie, of North Chicago, Illinois, reported July 27 that Q2-2023 net revenue for its eye care products totaled $617 million, a 13.9 percent decline from $717 million in Q2-2022. Restasis revenue w...

8/22/2023
DiagnosticNewsletterRetinaSurgical
Weekly Corporate and Surgeon Poll, August 2023
Weekly Corporate and Surgeon Poll, August 2023

8/10/2023
AIBreakingDiagnosticGlaucomaRetina
Icahn School of Medicine at Mount Sinai Launches Ophthalmic-Focused AI Center
Icahn School of Medicine at Mount Sinai Launches Ophthalmic-Focused AI Center

New York’s Icahn School of Medicine at Mount Sinai announced July 5 that it had launched the Center for Ophthalmic Artificial Intelligence and Human Health. The center will incorporate AI into educ...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more